PTC Therapeutics

PTCT • NASDAQ • Stock Fundamentals

PTC Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Klein, with a market cap of $6.2B.

Market Cap$6.2B

Employees995.0

CEOMatthew Klein

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 8 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about PTC Therapeutics

PTC Therapeutics (PTCT) has a market capitalization of $6.2B and trades on NASDAQ.

PTC Therapeutics has approximately 995 employees.